We are live on ! Find out more
EVGN icon

Evogene
EVGN

18 hedge funds and large institutions have $79.8M invested in Evogene in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 17 → 18 (+1)

0.32% less ownership

Funds ownership: 1.96% → 1.65% (-0.32%)

17% less capital invested

Capital invested by funds: $95.7M → $79.8M (-$15.9M)

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$3.1M
2
CS
Credit Suisse
Switzerland
+$1.97M
3
Jane Street
Jane Street
New York
+$545K
4
Barclays
Barclays
United Kingdom
+$27.1K
5
U
UBS
Switzerland
+$10.4K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$14.7M
2
Bank of America
Bank of America
North Carolina
-$2.02M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$1.47M
4
MCM
Moon Capital Management
New York
-$941K
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$372K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$42.5M – – –
Bank of America
2
Bank of America
North Carolina
$7.89M -$2.02M -10,654 -20%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$5.14M -$372K -1,961 -7%
Goldman Sachs
4
Goldman Sachs
New York
$5.03M -$14.7M -77,500 -75%
JP Morgan Chase
5
JP Morgan Chase
New York
$4.57M +$3.1M +16,371 +216%
MMH
6
Menora Mivtachim Holdings
Israel
$4.34M -$233K -1,230 -5%
CS
7
Credit Suisse
Switzerland
$1.98M +$1.97M +10,404 New
SM
8
Senvest Management
New York
$1.82M -$88.7K -468 -5%
LP
9
LMR Partners
United Kingdom
$1.51M +$15K +79 New
HP
10
Harvey Partners
New York
$1.14M – – –
U
11
UBS
Switzerland
$999K +$10.4K +55 +1%
Barclays
12
Barclays
United Kingdom
$964K +$27.1K +143 +3%
Canada Pension Plan Investment Board
13
Canada Pension Plan Investment Board
Ontario, Canada
$955K – – –
Jane Street
14
Jane Street
New York
$547K +$545K +2,874 New
MCM
15
Moon Capital Management
New York
$345K -$941K -4,968 -73%
Citigroup
16
Citigroup
New York
$91K -$758 -4 -0.8%
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$26K -$293K -1,544 -92%
Wells Fargo
18
Wells Fargo
California
$11K -$28K -148 -71%
HSBC Holdings
19
HSBC Holdings
United Kingdom
– -$1.47M -7,500 Closed
TRCT
20
Tower Research Capital (TRC)
New York
– -$6K -30 Closed

EVGN Hedge Fund Activity: Q1 2014 in Review

18 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q1 2014, worth a combined $79.8M — down 17% from $95.7M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EVGN positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 9 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $3.1M. The largest seller was Goldman Sachs, cutting an estimated $14.7M.

  • 18 institutional investors held Evogene (EVGN) as of Q1 2014, up from 17 in Q4 2013.
  • Funds reported $79.8M of Evogene stock for Q1 2014, down 17% quarter-over-quarter.
  • 3 funds opened new Evogene positions in Q1 2014 and 2 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q1 2014 was JP Morgan Chase, an estimated $3.1M added.
  • The largest Evogene seller in Q1 2014 was Goldman Sachs, an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2014.